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INTRODUCTION 
Improvements in breast reconstruction technique have sig-
nificantly enhanced the quality of life for most patients with 
breast cancer. Therapeutic standards have evolved from radi-
cal intervention to skin-sparing mastectomy (SSM) or most 
recently nipple-sparing mastectomy (NSM), advancing recon-
structive and aesthetic outcomes incrementally [1,2]. Al-
though NSM has raised safety issues, this technique is gener-
ally considered an acceptable oncologic option in properly se-
lected patients [3-5].
The demand for immediate breast reconstruction following 
conservative mastectomy has increased, with implant-based 
reconstruction most commonly pursued. According to Albornoz 
et al. [6], approximately 80% of all breast reconstructions per-
formed in the United States involve prosthetic devices, and 
the vast majority are implanted immediately, placed at the 
time of mastectomy. When performing immediate implant-
based breast reconstruction, it is still debatable whether a sin-
gle-stage, direct-to-implant (DTI) strategy or a two-stage (tis-
sue expander/implant) solution is best.
NSM with immediate prosthetic reconstruction may be 
performed using either a one-stage or two-stage method. Pro-
ponents of the one-stage DTI approach emphasize its low re-
vision rate, fewer operations, reduced overall cost, and excel-
lent patient outcomes [7-9]. Those supporting the two-stage 
method cite the opportunity to recontour and select an ideal 
device at second stage, reduced capsular contracture risk in 
the setting of postmastectomy radiation, lower unplanned re-
vision rate, as well as excellent patient outcomes [10,11].
When performing NSM, the choice of incision may be 
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Purpose: In properly selected patients with breast cancer, nipple-
sparing mastectomy (NSM) is generally considered safe by on-
cologic standards. We examined two groups of patients who 
underwent direct-to-implant (DTI) reconstruction after NSM, 
comparing complications encountered, revision rates, and aes-
thetic outcomes. The patients were stratified based on type of 
surgical incision and assigned to inframammary fold (IMF) and 
non-IMF groups. Methods: We investigated 141 patients (145 
breasts) subjected to NSM and immediate DTI reconstruction 
between 2013 and 2016. A total of 62 breasts (in 58 patients) 
were surgically removed via IMF incisions, with the other 83 
breasts (in 83 patients) removed by non-IMF means. Results: 
Complications associated with IMF (n=62) and non-IMF (n=83) 
incisions were as follows: skin necrosis (IMF, 9; non-IMF, 18); he-
matoma (IMF, 3; non-IMF, 4); seroma (IMF, 8; non-IMF, 4); mild 
capsular contracture (IMF, 4; non-IMF, 7); and tumor recurrence 
(IMF, 2; non-IMF, 8). Surgical revisions were counted as dupli-
cates (IMF, 18; non-IMF, 38). Aesthetic outcomes following IMF 
incisions were rated as very good (44.2%), good (23.1%), fair 
(23.1%), or poor (9.6%). Conclusion: IMF incision enables com-
plete preservation of the nipple-areolar complex, yielding superi-
or aesthetic results in immediate DTI breast reconstruction after 
NSM. The nature of incision used had no significant impact on 
postoperative complications or reoperation rates and had com-
parable oncologic safety to that of non-IMF incisions. IMF inci-
sions produced the least visible scarring and did not affect 
breast shape. Most patients were satisfied with the aesthetic 
outcomes. 
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problematic, given that numerous variations have reportedly 
shown merit. Alternatives include radial, transverse periareo-
lar, lateral, inferolateral, double concentric periareolar, vertical 
infra-areolar, and inframammary fold (IMF) incisions, with 
or without an axillary extension [12-15]. Endara et al. [16] 
have comprehensively addressed the process of choosing an 
appropriate incision for NSM. A radial or IMF incision is 
known to minimize scarring. 
Although no incision is ideal, some certainly should be 
avoided. Endara et al. [16] found similar rates of nipple necro-
sis for radial and IMF incisions (8.8% and 9.1%, respectively), 
whereas this rate was much higher (17.8%) for periareolar/
circumareolar incision lines. The highest incidence of nipple 
necrosis (81.8%) was recorded for a transareolar approach 
[16]. Using IMF incisions, the Beth Israel Deaconess group 
achieved an 82.0% nipple-areolar complex (NAC) survival 
rate in 17 breasts [17]. Blechman et al. [18] also reported a 
94.0% NAC survival rate; in our series, the NAC survival rate 
was 95.1%.
Both oncologic and plastic surgeons would nevertheless 
agree on the convenience of a non-IMF incision in perform-
ing NSM. Moreover, a clearer intraoperative view is enabled. 
The drawback is a potential for visible scarring and nipple de-
formity or positional changes as likely consequences of scar 
contractures.
In this study, we examined two groups of patients who un-
derwent DTI reconstruction after NSM, comparing complica-
tions encountered, revision rates, and aesthetic outcomes. The 
patients were stratified by the nature of the surgical incision, 
assigned to IMF and non-IMF groups. 
METHODS 
Patient population
We investigated 141 patients (145 breasts) subjected to 
NSM and immediate DTI reconstruction at Gangnam 
Severance Hospital, Seoul, Korea between 2013 and 2016. A 
total of 62 breasts (in 58 patients) were operated upon using 
IMF incisions, with the remaining 83 breasts (in 83 patients) 
involving non-IMF incisions. Detailed patient chart reviews 
were conducted retrospectively. The Yonsei University College 
of Medicine Institutional Review Board approved this study 
(number: 2017-08352014-001), and all participating patients 
granted informed consent. 
Prior to 2016, mastectomy and breast reconstruction at our 
facility entailed non-IMF incisions. Since then, IMF incision 
has been the method of choice. NSM is also our surgical pref-
erence and is typically reserved for smaller tumors (< 3 cm 
across) situated > 3 cm from the NAC. If undertaking SSM or 
confronting likely postmastectomy radiotherapy for nodal 
positivity, a tissue expander (rather than DTI) would be in-
serted.
Surgical technique
Preoperative markings were discussed and agreed upon by 
the oncologic and reconstructive teams. A lateral IMF inci-
sion was our preferred method. Incisions were made along 
the curvilinear skin crease, extending as far lateral as the 3 
o’clock position for the left breast (9 o’clock for the right breast) 
and extending as far inferior as the 6 o’clock position. Sentinel 
lymph node biopsies or axillary dissections were also attempt-
ed through such incisions. If broader exposure was needed, 
counter-incisions of the axilla or along previous scars were 
made.
Acellular dermal matrices (DermACELL® [LifeNet Health, 
Virginia Beach, USA]; MegaDerm® [L&C BIO, Seoul, Korea]; 
or AlloDerm® [LifeCell Corp., Branchburg, USA]) were regu-
larly used as inferolateral slings to expand inferior pockets and 
gain better IMF control. All permanent breast implants 
(Mentor Worldwide LLC, Santa Barbara, USA) were placed 
using dual plane technique (subpectoral and acellular dermal 
matrix positioning). 
Skin incisions were routinely sutured to deep tissue (3-0 
Vicryl; Ethicon, Bridgewater, USA), thereafter using 4-0 V-
LocTM (Medtronic, Minneapolis, USA) and 5-0 Monosof 
(Medtronic) layer by layer. Two drains were placed at the time 
of mastectomy and removed after ~2–3 weeks. In the interim, 
patients were maintained on intravenous or oral antibiotics to 
protect against indigenous skin flora.
Postoperative care 
Until the day of operation and on postoperative days 1 and 
2, methylprednisolone sodium succinate (125 mg Solu-
Medrol®; Pfizer, New York, USA) was injected twice daily. 
This regimen served to promote skin flap perfusion and pre-
vent postoperative edema.
As early as 2002, reports had surfaced on use of leukotriene 
inhibitors to treat capsular contractures [19,20]. The benefits 
of montelukast (Singulair®; Merck, Kenilworth, USA) in soft-
ening breasts and mitigating capsular contractures have since 
been documented in a number of studies. Our facility allows 
once-daily montelukast administration, starting on postoper-
ative day 7.
Surgical complications
Complications were defined as necrosis of mastectomy skin 
and/or NAC, necessitating surgical intervention; seroma; cap-
sular contracture; infection requiring intravenous antibiotics; 
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implant loss; and tumor recurrence. Incidences of various re-
operations in both groups were analyzed as well. To assess the 
impact of postoperative radiation on various complication 
and reoperation rates, subgroup analyses were performed, 
separating patients into postmastectomy radiation therapy 
(PMRT) and non-PMRT groups.
Aesthetic outcomes
All patients were photographed pre- and postoperatively by 
the plastic surgeon. Aesthetic outcomes were gauged through 
subjective evaluation of certain factors, including NAC posi-
tion, breast shape, and symmetry (Table 1), as suggested by 
Salibian et al. [21] Using a three-point scale, results were rated 
as very good, good, fair, or poor. Clinical examinations and 
reviews of photo documentation were carried out for this pur-
pose by two plastic surgeons and one oncologic surgeon. Bi-
lateral mastectomies in two patients were excluded. Subgroup 
analysis (PMRT vs. non-PMRT) was also conducted.
Statistical analysis 
Complication and reoperation data were analyzed statisti-
cally. Descriptive statistics and measures of central tendency 
were used to describe absolute and mean results, respectively, 
with analysis of binary datasets via t-test and invoking chi-
square analysis for proportional response comparisons. Fisher 
exact test was applied to small values. All computations relied 
on standard software (SPSS version 15.0.1 for Windows; SPSS 
Inc., Chicago, USA), setting significance at p< 0.05.
RESULTS
Therapeutic considerations
We analyzed 145 NSM procedures (unilateral, 141; bilateral, 
2). The IMF group accounted for 62 breasts in 58 patients 
(mean age, 46.4 ± 5.9 years; mean body mass index [BMI], 
22.7± 2.3 kg/m2). Neoadjuvant and adjuvant chemotherapy 
was given to six and 28 patients, respectively; 47 patients re-
ceived hormonal therapy; and 16 breasts were irradiated after 
reconstruction. The mean size of implanted prosthetics was 
219.9 ± 57.4 mL. In 62 DTI reconstructions, our oncologic 
breast surgeons performed sentinel lymph node biopsy in 46, 
axillary lymph node dissection in 13, and neither procedure 
in two. 
The non-IMF group accounted for 83 breasts in 83 patients 
(mean age, 45.2 ± 8.5 years; mean BMI, 22.6 ± 3.2 kg/m2). 
Neoadjuvant and adjuvant chemotherapy was given to three 
and 25 patients, respectively; 65 patients received hormonal 
therapy; and 14 breasts were irradiated after reconstruction. 
The mean size of implanted prosthetics was 255.3± 76.9 mL. 
In 83 DTI reconstructions, our oncologic breast surgeons per-
formed sentinel lymph node biopsy in 74 and axillary lymph 
node dissection in nine (Table 2).
Complications and reoperations
Procedural complications are summarized in Table 3. In the 
IMF group, skin necrosis (9/62, 14.5%), hematoma (3/62, 
4.8%), seroma (8/62, 12.9%), capsular contracture (4/62, 6.5%) 
and infection (4/62, 6.5%) were encountered. Severe compli-
cations requiring breast implant removal were limited to three 
instances (4.8%). One of these patients acquired a postopera-
tive infection and another developed severe capsular contrac-
ture after adjuvant radiotherapy. The third patient experienced 
extensive skin necrosis, which we debrided. The implant was 
then exchanged for a smaller one, anticipating a later reduc-
tion mammoplasty on the other side. There were two instanc-
Table 1. Aesthetic outcome categories 
Aesthetic evaluation factor Very good Good Fair Poor
NAC location Symmetrically positioned Mild displacement Moderate displacement Severe displacement
Breast shape No irregularity Mildly irregular Moderate irregularities Severely distorted
Symmetry Symmetric Mild asymmetry Moderate asymmetry Severe asymmetry
NAC=nipple-areolar complex. 
Table 2. Comparative demographics for direct-to-implant breast recon-
structions performed with IMF incisions and non-IMF incisions
Characteristic
IMF incision 
(n=58) 
No. (%)
Non-IMF incision 
(n=83) 
No. (%)
p-value
No. of breasts 62 83 0.001
   Unilateral 54 (87.1) 83 (100)
   Bilateral 8 (12.9) 0
Age (yr)* 46.4±5.9 45.2±8.5 0.804
BMI (kg/m²)* 22.7±2.3 22.6±3.2 0.874
Neoadjuvant chemotherapy 6 (10.3) 3 (3.6) 0.105 
Adjuvant chemotherapy 28 (48.3) 25 (30.1) 0.122 
Hormone therapy 47 (81.0) 65 (78.3) 0.431 
Postmastectomy radiotherapy 16 (27.6) 14 (16.9) 0.094 
Implant volume (mL)* 219.9±57.4 255.3±76.9 <0.001
Node dissection 
   Sentinel lymph node biopsy 46 (79.3) 74 (89.2) 0.085 
   Axillary lymph node dissection 13 (22.4) 9 (10.8) 0.053 
   No procedure 2 (3.4) 0 0.167 
IMF= inframammary fold; BMI=body mass index.
*Mean±SD.
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es of tumor recurrence (3.2%), each adequately managed by 
oncologic surgeons. 
In the non-IMF group, skin necrosis (18/83, 21.7%), hema-
toma (4/83, 4.8%), seroma (4/83, 4.8%), capsular contracture 
(7/83, 8.4%), infection (10/83, 12.0 %), implant removal (7/83, 
8.4%), and tumor recurrence (8/83, 9.6%) were recorded. In 
the IMF (vs. non-IMF) group, capsular contracture (p =  
0.656), infection (p= 0.259), implant loss (p= 0.398), and tu-
mor recurrence (p= 0.132) rates tended to be lower, and the 
risk of skin necrosis (p= 0.030) was significantly less. Howev-
er, there were no significant between-group differences in 
terms of complications (Table 3, Figures 1 and 2).
We also investigated reoperations for secondary correc-
tions, which were counted as duplicates. Results are shown in 
Figure 1. Representative reconstructive outcome: a 43-year-old woman with ductal carcinoma in situ of left breast. (A) Preoperative view. (B) 
Symmetric nipple-areolar complex position and breast shape in immediate postoperative state.
Figure 2. Representative reconstructive outcome: a 40-year-old woman with mucinous carcinoma of left breast. (A) Preoperative status, prior to 
nipple-sparing mastectomy (via inframammary incision) removing 464 g of tissue. (B) Outcome 6 months after immediate direct-to-implant recon-
struction.
A
A
B
B
Table 3. Postoperative complications in patients undergoing DTI breast 
reconstruction following conservative mastectomy through IMF incision 
and non-IMF incision
Complication
Total 
DTI 
(n=145)
No. (%)
IMF 
incision 
(n=62) 
No. (%) 
Non-IMF 
incision 
(n=83) 
No. (%)
p-value
Skin breakdown/necrosis 27 (18.6) 9 (14.5) 18 (21.7) 0.030 
Hematoma 7 (4.8) 3 (4.8) 4 (4.8) 0.067 
Seroma 12 (8.3) 8 (12.9) 4 (4.8) 0.080 
Capsular contracture 11 (7.6) 4 (6.5) 7 (8.4) 0.656 
Infection 14 (9.7) 4 (6.5) 10 (12.0) 0.259 
Implant loss 10 (6.9) 3 (4.8) 7 (8.4) 0.398 
Recurrence 10 (6.9) 2 (3.2) 8 (9.6) 0.132 
Each complication was counted in duplicate.
DTI=direct-to-implant; IMF= inframammary fold.
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Table 4. In the IMF group, there were six skin flap revisions 
(9.7%), three hematoma evacuations (4.8%), two capsular 
contracture corrections (3.2%), three contralateral augmenta-
tion mammoplasties (4.8%), three implant extractions (4.8%), 
and one implant exchange (1.6%). In the non-IMF group, 
there were 13 skin flap revisions (15.7%), four hematoma 
evacuations (4.8%), one capsular contracture correction 
(1.2%), three scar revisions (3.6%), three contralateral aug-
mentation mammoplasties (3.6%), four implant extractions 
(4.8%), and 10 implant exchanges (12.0%). The rate of implant 
exchange owing to size mismatch was significantly lower in 
the IMF (vs. non-IMF) group (p= 0.019).
Subgroup analyses
In subgroup analysis, a higher incidence of complications 
was evident in the PMRT (vs. non-PMRT) group across all 
fields, including skin necrosis (17/30, 56.7%), hematoma 
(4/30, 13.3%), seroma (9/30, 30.0%), capsular contracture 
(9/30, 30.0%), infection (10/30, 33.3%), implant loss (8/30, 
26.7%) and tumor recurrence (7/30, 23.3%). Again, skin ne-
crosis in the IMF (vs. non-IMF) group was significantly less 
(p= 0.024), but no other significant differences emerged (Ta-
ble 5). 
PMRT had no apparent impact on reoperation outcomes, 
and there were no significant differences according to type of 
incision (Table 6).
Aesthetic outcomes
To evaluate aesthetic outcomes, we compared pre- and 
postoperative photos. In the IMF group (n= 58), two patients 
(four mastectomies) were excluded, and postoperative follow-
up photos were lacking in four patients. In the non-IMF 
group (n= 83), 28 patients also lacked follow-up photos. Ulti-
mately, 107 patients (IMF, 52; non-IMF, 55) were eligible for 
review and comparison (Table 7). 
Aesthetic outcomes in the IMF group were rated as follows: 
very good, 44.2% (23/52); good, 23.1% (12/52); fair, 23.1% 
(12/52); and poor, 9.6% (5/52). Of the 12 patients with fair re-
sults, six had received postoperative radiotherapy and two had 
experienced intractable seromas, leading to deep wound in-
fections. The other four patients were free of comorbidities. 
One of the five patients with poor results showed breast asym-
metry, having undergone implant removal for postoperative 
infection. Skin flap necrosis occurring in another three pa-
tients required surgical revision, and a capsular contracture 
necessitated capsulotomy and implant exchange.
Aesthetic outcomes in the non-IMF incision group were 
Table 4. Reoperation outcomes in patients undergoing DTI breast re-
construction following conservative mastectomy through IMF incision 
and non-IMF incision 
Reoperation
Total 
DTI 
(n=145)
No. (%) 
IMF 
incision
(n=62)
No. (%) 
Non-IMF 
incision 
(n=83)
No. (%)
p-value
Skin flap revision 19 (13.1) 6 (9.7) 13 (15.7) 0.291
Hematoma evacuation 7 (4.8) 3 (4.8) 4 (4.8) 0.996
Capsular contracture  
correction
3 (2.1) 2 (3.2) 1 (1.2) 0.398
Scar revision 3 (2.1) 0 3 (3.6) 0.130
Incision and drainage 
due to infection
0 0 0
Contralateral augmentation 
mammoplasty due to 
size mismatch 
6 (4.1) 3 (4.8) 3 (3.6) 0.714
Implant extraction 7 (4.8) 3 (4.8) 4 (4.8) 0.996
Implant change 11 (7.6) 1 (1.6) 10 (12.0) 0.019
Liposuction 0 0 0
Fat graft 0 0 0
Each complication was counted in duplicate.
DTI=direct-to-implant; IMF= inframammary fold.
Table 5. Subgroup analysis of postoperative complications based on PMRT 
Complication
PMRT (n=30) Non-PMRT (n=115)
Total 
DTI 
No. (%) 
IMF 
incision 
(n=16) 
No. (%)
Non-IMF 
incision 
(n=14) 
No. (%)
p-value
Total 
DTI 
No. (%)   
IMF 
incision 
(n=46) 
No. (%)
Non-IMF 
incision 
(n=69) 
No. (%)
p-value
Skin breakdown/necrosis 17 (56.7) 6 (37.5) 11 (78.6) 0.024 10 (8.7) 3 (6.5) 7 (10.1) 0.499 
Hematoma 4 (13.3) 2 (12.5) 2 (14.3) 0.886 3 (2.6) 1 (2.2) 2 (2.9) 0.811 
Seroma 9 (30.0) 6 (37.5) 3 (21.4) 0.338 3 (2.6) 2 (4.3) 1 (1.4) 0.339 
Capsular contracture 9 (30.0) 3 (18.8) 6 (42.9) 0.151 2 (1.7) 1 (2.2) 1 (1.4) 0.771 
Infection 10 (33.3) 3 (18.8) 7 (50.0) 0.070 4 (3.5) 1 (2.2) 3 (4.3) 0.533 
Implant loss 8 (26.7) 3 (18.8) 5 (35.7) 0.295 2 (1.7) 0 2 (2.9) 0.244 
Recurrence 7 (23.3) 1 (6.3) 6 (42.9) 0.222 3 (2.6) 1 (2.2) 2 (2.9) 0.811 
Each complication was counted in duplicate.
PMRT=postmastectomy radiation therapy; DTI=direct-to-implant; IMF= inframammary fold. 
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rated as follows: very good, 16.4% (9/55); good, 32.7% (18/55); 
fair, 29.1% (16/55); and poor, 21.8% (12/55). Of the 16 pa-
tients with fair results, most developed capsular contracture 
or implant malposition. In those rated as poor, some showed 
capsular contracture or mismatched implant size. There were 
also instances of implant malposition or skin necrosis needing 
reoperation. Outcomes rated as very good were significantly 
more numerous in the IMF (vs. non-IMF) group (p= 0.002). 
In subgroup analysis, the aesthetic superiority of the IMF 
incision was upheld in the non-PMRT group (n= 78), with 
significantly more patients rated very good (p< 0.001) and 
fewer rated as poor (p= 0.209). However, in breast reconstruc-
tions performed after PMRT (n= 29), there were no signifi-
cant between-group differences (IMF vs. non-IMF) (Table 8). 
DISCUSSION
Presently, NSM is a valid surgical option for treating breast 
cancer in selected patients. The combination of NSM and im-
mediate breast reconstruction has been gaining traction as a 
Table 6. Subgroup analysis of reoperation outcomes based on PMRT 
Reoperation
PMRT (n=30) Non-PMRT (n=115)
Total 
DTI 
No. (%) 
IMF 
incision
(n=16)
No. (%)
Non-IMF 
incision
(n=14)
No. (%)
p-value
Total 
DTI 
No. (%)   
IMF 
incision
(n=46)
No. (%)
Non-IMF 
incision
(n=69)   
No. (%)
p-value
Skin flap revision 5 (16.7) 1 (6.3) 4 (28.6) 0.102 11 (9.6) 2 (4.3) 9 (13.0) 0.120
Hematoma evacuation 0 1 (6.3) 2 (14.3) 0.464 4 (3.5) 2 (4.3) 2 (2.9) 0.678
Capsular contracture correction 2 (6.7) 1 (6.3) 1 (7.1) 0.922 1 (0.9) 1 (2.2) 0 0.219
Scar revision 1 (3.3) 0 1 (7.1) 0.277 2 (1.7) 0 2 (2.9) 0.244
Incision and drainage due to infection 0 0 0 0 0 0
Contralateral augmentation mammoplasty  
due to size missmatch   
2 (6.7) 1 (6.3) 1 (7.1) 0.922 4 (3.5) 2 (4.3) 2 (2.9) 0.678
Implant extraction 4 (13.3) 2 (12.5) 2 (14.3) 0.886 3 (2.6) 1 (2.2) 2 (2.9) 0.811
Implant change 4 (13.3) 1 (6.3) 3 (21.4) 0.222 7 (6.1) 0 7 (10.1) 0.026
Liposuction 0 0 0 0 0 0
Fat graft 0 0 0 0 0 0
Each complication was counted in duplicate.
PMRT=postmastectomy radiation therapy; DTI=direct-to-implant; IMF= inframammary fold.
Table 7. Aesthetic outcomes of the reconstructions 
Category 
Total DTI 
(n=107)
No. (%) 
IMF incision
(n=52)
No. (%) 
Non-IMF incision 
(n=55)
No. (%)  
p-value
Very good 32 (29.9) 23 (44.2) 9 (16.4) 0.002
Good 30 (28.0) 12 (23.1) 18 (32.7) 0.267
Fair 28 (26.2) 12 (23.1) 16 (29.1) 0.479
Poor 17 (15.9) 5 (9.6) 12 (21.8) 0.084
DTI=direct-to-implant; IMF= inframammary fold.
Table 8. Comparisons of the aesthetic outcomes of the breast reconstruction after PMRT status
Category
Non-PMRT (n=78) PMRT (n=29)   
Total 
DTI 
No. (%) 
IMF 
incision
(n=39)
No. (%) 
Non-IMF 
incision
(n=39)
No. (%)
p-value
Total 
DTI 
No. (%) 
IMF 
incision
(n=13)
No. (%) 
Non-IMF 
incision
(n=16) 
No. (%) 
p-value
Very good 27 (34.6) 21 (53.8) 6 (15.4) <0.001 5 (17.2) 2 (15.4) 3 (18.8) 0.811
Good 22 (28.2) 8 (20.5) 14 (35.9) 0.131 8 (27.6) 4 (30.8) 4 (25.0) 0.730
Fair 17 (21.8) 6 (15.4) 11 (28.2) 0.170 11 (37.9) 6 (46.2) 5 (31.3) 0.411
Poor 12 (15.4) 4 (10.3) 8 (20.5) 0.209 5 (17.2) 1 (7.7) 4 (25.0) 0.220
PMRT=postmastectomy radiation therapy; DTI=direct-to-implant; IMF= inframammary fold.
Direct to Implant Breast Reconstruction through Inframammary Fold Incision 219
https://doi.org/10.4048/jbc.2018.21.2.213 http://ejbc.kr
preferred surgical strategy [22-24], Furthermore, NSM tech-
niques now include removal of glandular tissue from the nip-
ple. This is a critical point of differentiation from prior subcu-
taneous mastectomy methods, where significant residual 
breast tissue was retained within and beneath the nipple. 
Benediktsson and Perbeck [25] have subsequently confirmed 
the oncologic safety of NSM, showing survival rates compara-
ble to those of conventional mastectomy, given a 13-year me-
dian follow-up period.
One- and two-stage prosthetic reconstructions have been 
performed at a number of institutions using an array of inci-
sions, including periareolar, inferior radial, inframammary, 
lateral, lateral radial, and inferolateral variations. The selection 
of a one- or two-stage approach in the setting of NSM is a 
complex process. Two-stage reconstruction yields better re-
sults, improving symmetry and implant position. Moreover, 
this strategy allows greater control over final breast volume 
and shape. However, cost is clearly a factor in that surgery is 
carried out at least twice. On the other hand, one-stage pros-
thetic reconstruction has few complications and confers rela-
tively good aesthetic outcomes. At our facility, two-stage pros-
thetic reconstruction is elected if skin flap volume is scant or 
postoperative radiotherapy is anticipated. 
As Endara et al. [16] have maintained, choosing the right 
incision for NSM facilitates both therapeutic and reconstruc-
tive efforts, preserving nipple-areola blood flow and produc-
ing an aesthetically favorable scar. Our oncologic surgeons 
generally relied upon non-IMF incisions until 2016. There-
after, IMF incisions were introduced, supported by ideal inci-
sion criteria (referenced earlier). Since this transition, patient 
satisfaction has improved, and surgeons are pleased with the 
results, hoping to even further improve postoperative aesthet-
ics. 
Herein, we examined patients undergoing one-stage DTI 
breast reconstruction via non-IMF incisions and those recon-
structed through IMF incisions, comparing complications. 
Skin necrosis in the IMF (n= 9, 14.5%) vs. non-IMF (n= 18, 
21.7%) group was significantly less prevalent (p = 0.030). 
There were nine instances of IMF-related skin necrosis in ear-
ly 2016, suggesting a learning curve for this this new method. 
By preserving 3rd and 4th intercostal perforators to fortify the 
blood supply, our oncologic surgeon successfully enhanced 
remnant skin flap thickness and viability, and skin necrosis 
was seldom seen later that year. Nevertheless, skin necrosis 
did remain more problematic in non-IMF (vs. IMF) incisions, 
especially at the lower pole of the breast. One potential expla-
nation is the gravitational pressure of implants against the 
lower reaches of skin flaps. 
In the evolution of NSM procedures, the advantage of im-
mediate breast reconstruction has brought to bear the impor-
tance of skin flap thickness in maintaining flap viability. Using 
4 to 5 mm flaps, some sources [26] have confined necrosis to 
~17%; through even thicker (10-mm) flaps, others have 
achieved rates < 5% [27,28]. Although thicker remnant flaps 
may indeed limit necrosis, no standard method is yet available 
for calibration, so consistency may be difficult to ensure. On 
average, our team generates 8-mm skin flaps. We are con-
vinced that such relatively thick flaps may contribute to the 
lower rates of flap necrosis presently achieved. This also ex-
plains the lesser mean implant size in our IMF group, com-
pared with the non-IMF group. The thin skin flaps formerly 
left behind were needed to cover larger sized implants. How-
ever, current (i.e., less aggressive) mastectomy trends leave rel-
atively thick skin flaps, restricting the size of breast implants. 
Rates of hematoma and seroma did not differ significantly 
by incision type, nor did the rate of capsular contractures, al-
beit somewhat premature. The follow-up period of ~1 year in 
the IMF group is possibly insufficient to reasonably assess 
contracture rates. Extended follow-up monitoring in future 
studies is truly needed. Rates of infection, implant loss, and 
tumor recurrence similarly showed no between-group differ-
ences. 
In a subgroup analysis comparing postoperative complica-
tions in PMRT and non-PMRT groups, the various complica-
tions encountered did not differ significantly. As for reopera-
tion outcomes, implant extraction was significantly more like-
ly in the non-IMF (vs. IMF) group. This may be related to the 
higher rate of skin necrosis shown by the non-IMF group. 
Our data further indicated that PMRT had no impact on re-
operation outcomes, regardless of incision type. 
A multiplicity of criteria has been developed for assessing 
the aesthetic outcomes of NSM, including patient self-assess-
ment, nipple sensitivity, postoperative scarring, nipple place-
ment, breast contour, and overall symmetry [17,29,30]. We 
used three criteria in our evaluations: NAC position, breast 
shape, and symmetry. IMF incisions concealed postoperative 
scarring and also resulted in fewer patient complaints. 
Bilateral reconstruction (IMF group: four mastectomies) 
was excluded in our analysis of aesthetic outcome, owing to 
an inherent advantage in terms of symmetry. Accordingly, 35 
patients (67.3%) in the IMF group were rated as having very 
good or good results, surpassing the corresponding rate 
(49.1%) in the non-IMF group. In the IMF (vs. non-IMF) 
group, significantly more patients were rated as very good 
(p= 0.002). 
Of note, we found no significant differences in aesthetic 
outcomes of IMF and non-IMF incisions after PMRT, regard-
less of aesthetic rating achieved. It may be that PMRT effects 
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offset any aesthetic benefit conferred by IMF incisions. How-
ever, the aesthetic superiority of IMF (vs. non-IMF) incisions 
was upheld in non-PMRT subgroup analysis. Finally, because 
aesthetic outcomes were evaluated by our staff plastic sur-
geons, bias cannot be ruled out.
In conclusion, the use of IMF incisions for DTI breast re-
construction after NSM allows complete preservation of the 
NAC, with superior aesthetic results. We found that related 
postoperative complications, secondary corrective operations, 
and oncologic safety all compared favorably with non-IMF 
incisions. Moreover, IMF incisions produced the least visible 
scars and did not affect breast shape. Most patients expressed 
satisfaction with their aesthetic outcomes. 
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